Back to Search
JULIA BENEDETTI, MD
MD
Dermatology Physician
NPI: 1912135153IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
256477(MA)
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 2009
Research & Publications (20)
Obstructive sleep apnea: Part II. Surgical approaches to sleep apnea.
PMID 15301662·J Long Term Eff Med Implants·2004
4-observational
The value of physical performance tests for predicting therapy outcome in patients with subacute low back pain: a prospective cohort study.
PMID 19363624·Eur Spine J·2009
2-rct
Re-evaluation of blood mercury, lead and cadmium concentrations in the Inuit population of Nunavik (Québec): a cross-sectional study.
PMID 18518986·Environ Health·2008
8-other
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
PMID 18467725·J Clin Oncol·2008
4-observational
Enhancement of photocurrent generation and open circuit voltage in dye-sensitized solar cells using Li+ trapping species in the gel electrolyte.
PMID 18292910·Chem Commun (Camb)·2008
8-other
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.
PMID 17876008·J Clin Oncol·2007
8-other
Impact of hospital volume on recurrence and survival after surgery for gastric cancer.
PMID 17435550·Ann Surg·2007
2-rct
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
PMID 17050876·J Clin Oncol·2006
3-trial
Cancer research training: the Southwest Oncology Group young investigator training program (YITP).
PMID 17020517·J Cancer Educ·2006
8-other
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
PMID 16877719·J Clin Oncol·2006
3-trial
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.
PMID 16260700·J Clin Oncol·2005
4-observational
Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.
PMID 16098253·Clin Colorectal Cancer·2005
4-observational
Asynchronous communication among clinical researchers: a study for systems design.
PMID 16023408·Int J Med Inform·2005
8-other
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
PMID 15774775·J Clin Oncol·2005
3-trial
Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma.
PMID 15693031·Cancer·2005
4-observational
An ethnographic study of collaborative clinical trial protocol writing.
PMID 15361057·Stud Health Technol Inform·2004
8-other
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.
PMID 15292717·Invest New Drugs·2004
3-trial
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
PMID 15122082·Invest New Drugs·2004
3-trial
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
PMID 15067028·J Clin Oncol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20 WALL ST
BURLINGTON, MA 01803 - Phone
- (781) 744-5115
Quick Facts
- NPI
- 1912135153
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile